{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:35:13Z","timestamp":1777610113153,"version":"3.51.4"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020152","name":"Madrigal Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020152","name":"Madrigal Pharmaceuticals, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020152","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/13696998.2024.2393952","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:19:28Z","timestamp":1724041168000},"page":"1108-1118","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8729-7435","authenticated-orcid":false,"given":"Jesse","family":"Fishman","sequence":"first","affiliation":[{"name":"Former Employee of Madrigal Pharmaceuticals, Inc.","place":["West Conshohocken, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0263-9384","authenticated-orcid":false,"given":"Yestle","family":"Kim","sequence":"additional","affiliation":[{"name":"Madrigal Pharmaceuticals, Inc","place":["West Conshohocken, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4976-904X","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Paris\u00e9","sequence":"additional","affiliation":[{"name":"Medicus Economics, LLC","place":["Boston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6471-9936","authenticated-orcid":false,"given":"Eric","family":"Bercaw","sequence":"additional","affiliation":[{"name":"Medicus Economics, LLC","place":["Boston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Smith","sequence":"additional","affiliation":[{"name":"Former Employee of Medicus Economics, LLC.","place":["Boston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"e_1_3_4_5_1","unstructured":"New MASLD Nomenclature | AASLD. 2024. Available from: https:\/\/www.aasld.org\/new-masld-nomenclature"},{"key":"e_1_3_4_6_1","unstructured":"Foundation AL. Nash complications. 2024."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1550065"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.027"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30254"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.04.025"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00020-0"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.36469\/jheor.2024.92223"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.24069"},{"key":"e_1_3_4_17_1","volume-title":"REZDIFFRA (resmetirom): highlights of prescribing information","author":"Madrigal Pharmaceuticals Inc","year":"2024","unstructured":"Madrigal Pharmaceuticals Inc. REZDIFFRA (resmetirom): highlights of prescribing information. West Conshohocken (PA): Madrigal Pharmaceuticals, Inc; 2024."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"e_1_3_4_19_1","unstructured":"Micromedex Red Book Online Search. Truven health analytics. 2024. Available from: http:\/\/www.micromedexsolutions.com"},{"key":"e_1_3_4_20_1","unstructured":"U.S. Census Bureau of Labor Statistics. Consumer price index for all urban consumers: medical care (CUSR0000SAM). 2024. Available from: https:\/\/www.bls.gov\/data\/"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.2291"},{"key":"e_1_3_4_22_1","unstructured":"U.S. Census Bureau. Table H-01. health insurance coverage status and type of coverage by selected characteristics for all people. 2021."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.09.945"},{"key":"e_1_3_4_24_1","unstructured":"Madrigal Pharmaceuticals I. Data on file. 2024."},{"key":"e_1_3_4_25_1","unstructured":"Center SHADA. Health insurance coverage type by age. 2023."},{"key":"e_1_3_4_26_1","unstructured":"Centers for Medicare & Medicaid Services. Medicare beneficiaries use of medicare services. 2021."},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1814"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101167"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100067"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199760"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.010"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15679"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.12.010"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02726-2"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(24)04199-4"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-022-00440-x"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.064"},{"key":"e_1_3_4_38_1","unstructured":"Services CfMM. Physician fee schedule. 2023."},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-022-00370-2"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.37134\/ibej.Vol16.1.4.2023"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07333-z"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000623"},{"key":"e_1_3_4_43_1","unstructured":"Tice JA Suh K Fs Carlson JJ et\u00a0al. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH); draft evidence report. Institute for Clinical and Economic Review; 2023."},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28785"},{"key":"e_1_3_4_45_1","unstructured":"Study Details. A phase 3 study to evaluate the efficacy and safety of MGL-3196 (Resmetirom) in patients with NASH and fibrosis. 2024. Available from: ClinicalTrials.gov"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2024.2393952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:38:58Z","timestamp":1772779138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2024.2393952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/13696998.2024.2393952"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2024.2393952","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}